Roux-en-Y gastric bypass, which typically involves a small gastric pouch, a 50cm biliary limb, and a 150cm alimentary limb, has emerged as one of the most effective solutions for morbid obesity and ...

Purpose Pharmacokinetic considerations in patients who have undergone Roux-en-Y gastric bypass (RYGB) are explored. Summary The prevalence of obesity, especially morbid obesity, has dramatically ...

Pharmacokinetic Considerations in Roux-en-Y Gastric Bypass Patients April Smith; Brian Henriksen; Andrew Cohen Disclosures Am J Health Syst Pharm. 2011;68 (23):2241-2247.

In our comparison of uncut Roux-en-Y with Roux-en-Y reconstruction, uncut Roux-en-Y reconstruction may have little or no effect on major postoperative complications and incidence of anastomotic ...